Published in Nat Neurosci on June 19, 2017
Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94
Targeted capture and massively parallel sequencing of 12 human exomes. Nature (2009) 33.96
A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet (2014) 14.56
A global reference for human genetic variation. Nature (2015) 12.85
Analysis of protein-coding genetic variation in 60,706 humans. Nature (2016) 11.83
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet (2006) 11.14
Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med (2012) 10.80
FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell (2011) 8.46
Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet (2012) 8.42
De novo mutations in epileptic encephalopathies. Nature (2013) 7.42
Rate, molecular spectrum, and consequences of human mutation. Proc Natl Acad Sci U S A (2010) 7.07
De novo mutations in schizophrenia implicate synaptic networks. Nature (2014) 6.59
Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science (2012) 6.21
The contribution of de novo coding mutations to autism spectrum disorder. Nature (2014) 5.94
De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet (2010) 5.72
Neuroligins determine synapse maturation and function. Neuron (2006) 5.70
Synaptic AMPA receptor plasticity and behavior. Neuron (2009) 5.58
Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30
De novo mutations in histone-modifying genes in congenital heart disease. Nature (2013) 5.15
Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell (2011) 4.58
Whole-genome sequence variation, population structure and demographic history of the Dutch population. Nat Genet (2014) 4.33
Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell (2012) 4.03
De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am J Hum Genet (2012) 3.58
ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res (2015) 3.38
Large-scale discovery of novel genetic causes of developmental disorders. Nature (2014) 3.33
Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell (2013) 3.26
Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nat Genet (2014) 3.21
Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene. Nature (1997) 3.10
De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet (2012) 2.86
Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome. Nat Genet (2011) 2.52
Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am J Hum Genet (2013) 2.47
Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation. Genome Res (2013) 2.29
Mutation of a glutamate receptor motif reveals its role in gating and delta2 receptor channel properties. Nat Neurosci (2000) 2.20
Whole-genome sequencing of quartet families with autism spectrum disorder. Nat Med (2015) 2.20
Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder. Am J Hum Genet (2013) 2.15
Disruptive CHD8 mutations define a subtype of autism early in development. Cell (2014) 2.05
The role of de novo mutations in the genetics of autism spectrum disorders. Nat Rev Genet (2014) 1.96
Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci. Neuron (2015) 1.91
Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. Epilepsia (2013) 1.78
A genotype-first approach to defining the subtypes of a complex disease. Cell (2014) 1.72
Excess of rare, inherited truncating mutations in autism. Nat Genet (2015) 1.62
De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol Psychiatry (2014) 1.62
Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nat Commun (2014) 1.59
A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP. Nat Genet (2014) 1.55
Impaired regulation of synaptic strength in hippocampal neurons from GluR1-deficient mice. J Physiol (2003) 1.55
Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors. Mol Psychiatry (2007) 1.53
Multiple evidence strands suggest that there may be as few as 19,000 human protein-coding genes. Hum Mol Genet (2014) 1.51
CRAVAT: cancer-related analysis of variants toolkit. Bioinformatics (2013) 1.43
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies. Science (2015) 1.36
Effects of the lurcher mutation on GluR1 desensitization and activation kinetics. J Neurosci (2004) 1.27
Conserved structural and functional control of N-methyl-D-aspartate receptor gating by transmembrane domain M3. J Biol Chem (2005) 1.27
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry (2011) 1.25
MIPgen: optimized modeling and design of molecular inversion probes for targeted resequencing. Bioinformatics (2014) 1.23
Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome. Am J Hum Genet (2012) 1.22
Genetic aspects of autism spectrum disorders: insights from animal models. Front Cell Neurosci (2014) 1.10
Exome sequencing identifies de novo gain of function missense mutation in KCND2 in identical twins with autism and seizures that slows potassium channel inactivation. Hum Mol Genet (2014) 1.08
Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability. Nat Neurosci (2016) 1.07
Prevalence and architecture of de novo mutations in developmental disorders. Nature (2017) 1.05
A new growth deficiency syndrome. Clin Genet (1981) 1.04
Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA. Am J Hum Genet (2015) 1.03
PTPN11 mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13. Hum Mutat (2002) 1.02
Whole-exome sequencing improves the diagnosis yield in sporadic infantile spasm syndrome. Clin Genet (2015) 1.01
The Lurcher mutation of an alpha-amino-3-hydroxy-5-methyl- 4-isoxazolepropionic acid receptor subunit enhances potency of glutamate and converts an antagonist to an agonist. J Biol Chem (2000) 1.01
The chromatin remodeller CHD8 is required for E2F-dependent transcription activation of S-phase genes. Nucleic Acids Res (2013) 1.01
Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID. Mol Psychiatry (2015) 1.01
SynaptomeDB: an ontology-based knowledgebase for synaptic genes. Bioinformatics (2012) 0.99
MuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures. Hum Genet (2013) 0.99
The 2016 database issue of Nucleic Acids Research and an updated molecular biology database collection. Nucleic Acids Res (2016) 0.94
De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample. Schizophr Res (2015) 0.93
Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy. Genet Med (2016) 0.91
GRID2 mutations span from congenital to mild adult-onset cerebellar ataxia. Neurology (2015) 0.86
De novo SCN2A splice site mutation in a boy with Autism spectrum disorder. BMC Med Genet (2014) 0.84
Death and survival of heterozygous Lurcher Purkinje cells in vitro. Dev Neurobiol (2009) 0.83
Whole-exome sequencing and neurite outgrowth analysis in autism spectrum disorder. J Hum Genet (2015) 0.83
3D visualization of the regional differences. Mol Psychiatry (2015) 0.81
Proteins linked to autosomal dominant and autosomal recessive disorders harbor characteristic rare missense mutation distribution patterns. Hum Mol Genet (2015) 0.81
Neocortical neurogenesis and the etiology of autism spectrum disorder. Neurosci Biobehav Rev (2016) 0.80
Whole-Exome Sequencing in a South American Cohort Links ALDH1A3, FOXN1 and Retinoic Acid Regulation Pathways to Autism Spectrum Disorders. PLoS One (2015) 0.79
Molecular subtyping and improved treatment of neurodevelopmental disease. Genome Med (2016) 0.79
denovo-db: a compendium of human de novo variants. Nucleic Acids Res (2016) 0.79
DSM-5 and psychiatric genetics - round hole, meet square peg. Biol Psychiatry (2015) 0.77
The 24th annual Nucleic Acids Research database issue: a look back and upcoming changes. Nucleic Acids Res (2017) 0.75
A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP. Nat Genet (2014) 1.55
X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes. Mol Psychiatry (2015) 1.28
Tissue-specific variation in DNA methylation levels along human chromosome 1. Epigenetics Chromatin (2009) 1.19
Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID. Mol Psychiatry (2015) 1.01
HCFC1 loss-of-function mutations disrupt neuronal and neural progenitor cells of the developing brain. Hum Mol Genet (2015) 0.85
Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases. Nat Genet (2017) 0.84
Xp11.2 microduplications including IQSEC2, TSPYL2 and KDM5C genes in patients with neurodevelopmental disorders. Eur J Hum Genet (2015) 0.83
FRA2A is a CGG repeat expansion associated with silencing of AFF3. PLoS Genet (2014) 0.82
A patient showing features of both SBBYSS and GPS supports the concept of a KAT6B-related disease spectrum, with mutations in mid-exon 18 possibly leading to combined phenotypes. Eur J Med Genet (2015) 0.81
Detection and interpretation of genomic structural variation in health and disease. Expert Rev Mol Diagn (2013) 0.80
DNA Diagnostics of Hereditary Hearing Loss: A Targeted Resequencing Approach Combined with a Mutation Classification System. Hum Mutat (2016) 0.80
denovo-db: a compendium of human de novo variants. Nucleic Acids Res (2016) 0.79
De novo genic mutations among a Chinese autism spectrum disorder cohort. Nat Commun (2016) 0.78
Anophthalmia, hearing loss, abnormal pituitary development and response to growth hormone therapy in three children with microdeletions of 14q22q23. Mol Cytogenet (2014) 0.78
A 15 Mb large paracentric chromosome 21 inversion identified in Czech population through a pair of flanking duplications. Mol Cytogenet (2014) 0.77
A robust protocol to increase NimbleGen SeqCap EZ multiplexing capacity to 96 samples. PLoS One (2015) 0.76
AKAP2 identified as a novel gene mutated in a Chinese family with adolescent idiopathic scoliosis. J Med Genet (2016) 0.76
USP9X deubiquitylating enzyme maintains RAPTOR protein levels, mTORC1 signalling and proliferation in neural progenitors. Sci Rep (2017) 0.76
The Koolen-de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant. Eur J Hum Genet (2015) 0.75
Genome-wide copy number variation analysis in a Chinese autism spectrum disorder cohort. Sci Rep (2017) 0.75
Hypophosphatasia due to uniparental disomy. Bone (2015) 0.75
Novel and ultra-rare damaging variants in neuropeptide signaling are associated with disordered eating behaviors. PLoS One (2017) 0.75
Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders. Mol Psychiatry (2017) 0.75
A genotype-first approach identifies an intellectual disability-overweight syndrome caused by PHIP haploinsufficiency. Eur J Hum Genet (2017) 0.75
A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome. J Neurodev Disord (2017) 0.75
Expression of Phosphodiesterase 4B cAMP-Specific Gene in Subjects With Cryptorchidism and Down's Syndrome. J Clin Lab Anal (2014) 0.75
Variant in the X-chromosome spliceosomal gene GPKOW causes male-lethal microcephaly with intrauterine growth restriction. Eur J Hum Genet (2017) 0.75
Severe congenital neutropenia with neurological impairment due to a homozygous VPS45 p.E238K mutation: A case report suggesting a genotype-phenotype correlation. Am J Med Genet A (2015) 0.75
Multiplexed High Resolution Melting Assay for Versatile Sample Tracking in a Diagnostic and Research Setting. J Mol Diagn (2015) 0.75
Parental gonadal but not somatic mosaicism leading to de novo NFIX variants shared by two brothers with Malan syndrome. Am J Med Genet A (2019) 0.75
A Upf3b-mutant mouse model with behavioral and neurogenesis defects. Mol Psychiatry (2017) 0.75
Clinical and molecular characterization of an infant with a tandem duplication and deletion of 19p13. Am J Med Genet A (2015) 0.75
Fragile X syndrome. Nat Rev Dis Prim (2017) 0.75